Topic
Life Sciences
News
LaboratoryLife SciencesResearch Results
Canadian scientists take part in major international study on air pollution
July 15, 2004 by Lab Canada Ottawa, ON – July 15, 2004 – Canadian scientists will be among more than 500 researchers from five countries involved in a major international study on the movement of air pollution. Some 40 researchers from Canada will take part in…
News
General Science & ResearchLaboratoryLife Sciences
Novel technology said to reduce infectious prions from blood
July 13, 2004 by Lab Canada East Hills, NY – July 13, 2004 – Pall Corporation today unveiled a new technology that it says reduces prions from blood prior to a transfusion at the annual meeting of the International Society for Blood Transfusion (ISBT) in Edinburgh,…
News
General Science & ResearchLaboratoryLife Sciences
New fellowship focuses on arthritis research
July 12, 2004 by Lab Canada Vancouver, BC – July 12, 2004 – A PhD candidate at the University of British Columbia has been named by the Arthritis Research Centre of Canada (ARC) as the first recipient of the Pfizer Research Fellowship in Arthritis. The fellowship…
News
General Science & ResearchLaboratoryLife Sciences
CSMLS launches national campaign to promote laboratory safety
July 12, 2004 by Lab Canada Hamilton, ON – July 12, 2004 – The Canadian Society for Medical Laboratory Science is asking members to make safety a priority in their workplaces with its first-ever safety campaign. “The theme for our campaign is ‘Laboratory Safety – No…
News
General Science & ResearchLaboratoryLife SciencesResearch Results
$24M for research infrastructure support announced
June 29, 2004 by Lab Canada Ottawa, ON – June 29, 2004 – The Canada Foundation for Innovation’s board of directors today approved $23.8 million to support 124 projects involving 140 researchers at 40 research institutions across Canada. The support is coming through two funds: $18.3…
News
General Science & ResearchLaboratoryLife Sciences
Change of name for genetics research company
June 29, 2004 by Lab Canada Vancouver, BC – June 29, 2004 – Xenon Genetics announced today that, effective immediately, it has changed its name to Xenon Pharmaceuticals. It says the new name more accurately reflects its drug discovery and development focus and its goal of…
News
General Science & ResearchLaboratoryLife SciencesResearch Results
Research group to study cardiovascular benefits of traditional aboriginal medicine
June 28, 2004 by Lab Canada Saskatoon, SK – June 28, 2004 – A newly formed research group at the University of Saskatchewan is working with two northern Saskatchewan Aboriginal communities to study traditional First Nations medicine that may reduce hypertension and improve heart health. With…
News
General Science & ResearchLaboratoryLife Sciences
Co-chairs named for infectious disease committee
June 28, 2004 by Lab Canada Toronto, ON – June 28, 2004 – Queen’s epidemiologist Dr Dick Zoutman, director of infection control services at Kingston General Hospital, and Dr Dave Williams, medical officer of health for Thunder Bay, have been named co-chairs of Ontario’s new, permanent…
News
General Science & ResearchLaboratoryLife Sciences
Free online seminar on new techniques for simplifying FT-IR sampling
June 24, 2004 by Lab Canada Boston, MA – June 24, 2004 – On June 30, 2004, PerkinElmer says it will offer a free online seminar on the latest sampling techniques for FT-IR analysis. This seminar is available to anyone with an Internet connection and a…
News
General Science & ResearchLaboratoryLife Sciences
Major gift for cellular and biomolecular research centre slated to open in 2005
June 24, 2004 by Lab Canada Toronto, ON – June 24, 2004 – A renowned Toronto philanthropist has given the University of Toronto’s cutting-edge post-genomic research centre – the first in Canada – a financial vote of confidence with a $13 million donation. U of T…
News
General Science & ResearchLaboratoryLife SciencesResearch Results
Whole genome study discovers 10 new gene candidate regions in Crohn’s disease
June 22, 2004 by Lab Canada Montreal, QC & Mountain View, CA – June 22, 2004 – Biotech companies Galileo Genomics and Perlegen Sciences say they have completed a linkage disequilibrium-based genome-wide scan (LD-GWS) of Crohn’s disease in the Quebec founder population. The study identified two…
News
General Science & ResearchLaboratoryLife Sciences
Gifts totaling $3.7 million to fund lab devoted to gastrointestinal research
June 21, 2004 by Lab Canada Vancouver, BC – June 21, 2004 – The BC Children’s Hospital Foundation today announced a $2-million endowment from the CHILD foundation that will be dedicated to care and research for children with Crohn’s disease and other inflammatory bowel diseases (IBD).…
News
General Science & ResearchLaboratoryLife SciencesNew Technology & Applications
Alberta and Korea finding common ground in science and technology
June 21, 2004 by Lab Canada Edmonton, AB – June 21, 2004 – Alberta and South Korea have a new agreement to work together on science and technology related projects. A letter of intent was signed in Seoul earlier this month by the province’s premier, Ralph…
News
LaboratoryLife SciencesResearch Results
Report says cost-cutting still threatens Canada’s ability to sustain leading-edge research
June 17, 2004 by Lab Canada Toronto, ON – June 17, 2004 – The scientists warn that cost-cutting measures at the Meteorological Service of Canada (MSC), which began in the mid-1990s, will erode its ability to sustain leading-edge research. The report, released today, suggests that loss…
News
General Science & ResearchLaboratoryLife Sciences
Oral biology specialist joins Kane Biotech scientific board
June 17, 2004 by Lab Canada Winnipeg, MN – June 17, 2004 – Kane Biotech a biotechnology company that develops products to prevent and disperse bacterial biofilms, has appointed Dr Dennis Cvitkovitch to its scientific advisory board. Dr Cvitkovitch, who brings considerable experience in understanding harmful…
News
General Science & ResearchLaboratoryLife SciencesResearch Results
Scientists discover first cells that lead to retinoblastoma
June 14, 2004 by Lab Canada Toronto, ON – June 14 – Scientists at Toronto Western Hospital have discovered the specific cells in the eye that develop into retinoblastoma, the most common eye cancer in young children. The research suggests that these cells already have cancer-like…
News
General Science & ResearchLaboratoryLife Sciences
New combined biotech firm to focus on developing ocular, oncology, dermatology and urology products
June 14, 2004 by Lab Canada Vancouver, BC and Fort Collins, CO – June 14, 2004 – QLT and Atrix Laboratories say they have signed an agreement for QLT to acquire 100% of Atrix’s common stock for approximately $855 million in stock and cash, taking a…
News
General Science & ResearchLaboratoryLife Sciences
Senior management reorganization for Theratechnologies
June 14, 2004 by Lab Canada Montreal, QC – June 14, 2004 – Biotech company Theratechnologies has announced plans to hire a new chief executive and has promoted several senior executives, in order to prepare for late-stage product development and commercialization. The company’s president and current…
News
General Science & ResearchLaboratoryLife Sciences
Cytokine research pioneer joins Trillium Therapeutics’ scientific advisory board
June 14, 2004 by Lab Canada Toronto, ON – June 14, 2004 – Life sciences company Trillium Therapeutics says that Dr Marc Feldmann, a professor at Imperial College London and head of the Kennedy Institute of Rheumatology Division, has agreed to join the company’s scientific advisory…
News
LaboratoryLife Sciences
Canada’s healthcare crisis focus of town hall discussion at opening of Joint Congress of Medical Laboratory Science
June 7, 2004 by Lab Canada Hamilton, ON – June 7, 2004 – The crisis in Canada’s health care system will be the focus of a town hall discussion at opening ceremony of the Joint Congress of Medical Laboratory Science, Monday, June 14 at the Centennial…
News
LaboratoryLife Sciences
New study points out evidence based strategies from SARS to improve workplace safety
June 7, 2004 by Lab Canada Toronto, ON – June 4, 2004 – A new research report issued by the Change Foundation and the Ontario Hospital Association uses the SARS experience to identify future research opportunities to help prevent the spread of infectious diseases. "Protecting the…
News
General Science & ResearchLaboratoryLife SciencesResearch Results
Viventia Biotech expands clinical program in head and neck cancer
June 7, 2004 by Lab Canada Toronto, ON – June 7, 2004 – Biotech company Viventia Biotech says it has begun a second Phase I clinical trial for the treatment of head and neck cancer with its lead product candidate, Proxinium. This clinical trial involves a…
News
General Science & ResearchLaboratoryLife Sciences
Warnex accelerates development of GMO testing and meat identification kits
June 7, 2004 by Lab Canada Laval, QC – June 7, 2004 – Biotech firm Warnex says it has signed a licensing agreement with Irish company IdentiGEN to develop products incorporating IdentiGEN’s proprietary know-how and Warnex’s Genevision technology platform for the detection of genetically modified organisms…
News
General Science & ResearchLaboratoryLife Sciences
Toronto cancer hospital launches new research institute
June 2, 2004 by Lab Canada Toronto, ON – June 2, 2004 – Princess Margaret Hospital is launching a new research institute devoted to breast cancer, and it will be led by one of the country’s most respected and productive scientists. Dr Tak Mak, who has…
News
LaboratoryLife SciencesResearch Results
Canadian and Swedish scientists to collaborate on leading-edge genomics projects
June 1, 2004 by Lab Canada Stockholm, Sweden – June 1, 2004 – Professor Staffan Normark, executive director of the Swedish Foundation for Strategic Research today announced the approval of six new Swedish genomics and proteomics research projects, totalling an investment of US$2 million. All of…
News
LaboratoryLife Sciences
Angiotech partner announces sub-population data from its Taxus VI drug-eluting stent trial
May 31, 2004 by Lab Canada Vancouver, BC – May 31, 2004 – Angiotech Pharmaceuticals, a specialty pharmaceutical company that focusses on drug-coated medical devices and biomaterials, says its corporate partner, Boston Scientific announced nine-month sub-population data from its Taxus VI clinical trial. The Taxus technology…
News
LaboratoryLife Sciences
Cardiome presents to FDA advisory body
May 31, 2004 by Lab Canada Vancouver, BC – May 31, 2004 – Cardiovascular drug development company Cardiome Pharma says it will present information to the FDA Arthritis Drugs Advisory Committee on June 2. The presentation will focus on oxypurinol as a treatment for allopurinol-intolerant gout…
News
LaboratoryLife Sciences
Oncolytics Biotech starts patient treatment in UK Phase I clinical trial
May 31, 2004 by Lab Canada Calgary, AB – May 31, 2004 – Oncolytics Biotech says it has started patient treatment in its UK Phase I clinical trial investigating the systemic delivery of Reolysin as a treatment for patients with advanced or metastatic solid tumours. This…
News
LaboratoryLife Sciences
Altachem Pharma advances ACP-HIP Phase I clinical trial
May 31, 2004 by Lab Canada Edmonton, AB – May 31, 2004 – Altachem Pharma says it completed enrollment of the first group of four patients on May 14, 2004 for the ACP-HIP Phase I clinical trial and confirms its continued focus in advancing the development…
News
LaboratoryLife SciencesResearch Results
Avian flu genome sequence provides important new information
May 28, 2004 by Lab Canada Vancouver, BC – May 28, 2004 – The BC Cancer Agency’s Genome Sciences Centre (GSC), the BC Centre for Disease Control (BCCDC) and the Animal Health Centre, Ministry of Agriculture, Food and Fisheries (AHC) have worked together to complete the…
News
General Science & ResearchLaboratoryLife Sciences
Biotechnology firm enters agreement for value-added specialty oil products
May 28, 2004 by Lab Canada Calgary, AB – May 28 – Biotech company SemBioSys Genetics says it has executed a development agreement with Arcadia Biosciences to co-develop value-added specialty oil products with potential nutraceutical applications. Under the terms of the multi-year agreement, SemBioSys will use…
News
General Science & ResearchLaboratoryLife Sciences